Spyre Therapeutics
SYRE
SYRE
94 hedge funds and large institutions have $275M invested in Spyre Therapeutics in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 23 increasing their positions, 31 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
26% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 31
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
94
Holding in Top 10
2
Calls
$1K
Puts
–
Top Buyers
| 1 | +$8.05M | |
| 2 | +$2.91M | |
| 3 | +$2.66M | |
| 4 |
Axa
Paris,
France
|
+$2.16M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.71M |
Top Sellers
| 1 | -$7.63M | |
| 2 | -$3.42M | |
| 3 | -$1.5M | |
| 4 |
Renaissance Technologies
New York
|
-$1.47M |
| 5 |
BlackRock
New York
|
-$631K |